A supplier review is more useful when readers can tell how the reviewer reached its conclusions. An article that looks independent may rely entirely on the seller’s own materials, an affiliate relationship or a single selected sample. Those limitations should be visible.

State what was actually evaluated

A documentary review assesses records. An analytical review examines tested samples. A manufacturing audit evaluates a defined facility or process. These activities are not interchangeable. A review should name its scope and avoid implying that more work occurred than actually did.

For sample testing, explain how the material was obtained and which lot it represented. For documentation, distinguish records verified with the issuing organization from images supplied by a seller. For customer service, identify whether the experience was one transaction or a broader dataset.

Disclose incentives and uncertainty

FTC health-product guidance addresses endorsements and the need to substantiate underlying health claims. A personal experience does not become clinical evidence because the reviewer appears credible. Relevant commercial relationships should not be hidden behind an “honest review” label. FTC health products compliance guidance

Regulatory claims also require precise wording. FDA approval is not a general status that can be inferred from a business registration, a familiar molecule or professional-looking packaging. FDA explanation of approval claims

A responsible review can conclude that evidence is incomplete. It should not fill gaps with either endorsement or accusation. Where the reviewer could not verify a claim, the article should say so and explain why the missing information matters.

AXON offers this framework instead of an unverified review of a named competitor. No purchase, laboratory testing or audit was performed for this article. The intended lesson is how to distinguish a transparent assessment from promotional content that borrows the appearance of independent research.